BTG3 is reportedly a candidate tumor suppressor, as it inhibits cell proliferation and migration, and regulates cell cycle progression in several tumors, such as gastric cancer (Ren et al. 2015) and esophageal adenocarcinoma (Gou et al. 2015; Du et al. 2015). Here, BTG3 is linked to gastric cancer.